Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544611

MAHALIFE

img img img img
No Data Available

Mahamaya Lifesciences Ltd Share Price Update

As of the latest trading session, Mahamaya Lifesciences Ltd share price is currently at ₹ 197, which is up by ₹ 9.30 from its previous closing. Today, the stock has fluctuated between ₹ 187.00 and ₹ 197.05. Over the past year, Mahamaya Lifesciences Ltd has achieved a return of [-] %. In the last month alone, the return has been 66.06 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Mahamaya Lifesciences Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    461.00

  • P/E Ratio (TTM)

    35.94

  • Beta

    -0.64

  • Book Value / share

    48.77

  • Return on equity

    34.16%

  • EPS (TTM)

    5.51

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Mahamaya Lifesciences Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 264.15
Operating Expense 249.80
Net Profit 12.82
Net Profit Margin (%) 4.85
Earnings Per Share (EPS) 7.52
EBITDA 25.86
Effective Tax Rate (%) 25.72
Particulars MAR 2024 (Values in Cr)
Revenue 161.52
Operating Expense 155.29
Net Profit 5.47
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 43.80
EBITDA 14.35
Effective Tax Rate (%) 27.26
Particulars MAR 2023 (Values in Cr)
Revenue 137.02
Operating Expense 132.18
Net Profit 3.73
Net Profit Margin (%) 2.72
Earnings Per Share (EPS) 29.85
EBITDA 9.15
Effective Tax Rate (%) 28.40
Particulars MAR 2022 (Values in Cr)
Revenue 89.91
Operating Expense 86.14
Net Profit 2.80
Net Profit Margin (%) 3.11
Earnings Per Share (EPS) 22.44
EBITDA 6.27
Effective Tax Rate (%) 28.86
Particulars MAR 2025 (Values in Cr)
Book Value / Share 27.82
ROE % 34.93
ROCE % 25.79
Total Debt to Total Equity 1.52
EBITDA Margin 9.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 197.46
ROE % 23.67
ROCE % 21.04
Total Debt to Total Equity 1.79
EBITDA Margin 8.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 155.67
ROE % 21.34
ROCE % 20.05
Total Debt to Total Equity 1.24
EBITDA Margin 6.73
Particulars MAR 2022 (Values in Cr)
Book Value / Share 125.77
ROE % 17.31
ROCE % 15.20
Total Debt to Total Equity 1.22
EBITDA Margin 7.02
Particulars MAR 2025 (Values in Cr)
Book Value / Share 28.07
ROE % 34.16
ROCE % 25.56
Total Debt to Total Equity 1.50
EBITDA Margin 9.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 201.64
ROE % 24.37
ROCE % 21.29
Total Debt to Total Equity 1.76
EBITDA Margin 9.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share 157.84
ROE % 18.92
ROCE % 17.89
Total Debt to Total Equity 1.24
EBITDA Margin 6.75
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.99
Total Assets 188.35
Total Liabilities 188.35
Total Equity 49.42
Share Outstanding 17766200
Price to Book Ratio 0.00
Return on Assets (%) 6.87
Return on Capital (%) 12.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 112.06
Total Liabilities 112.06
Total Equity 24.65
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.65
Return on Capital (%) 6.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.04
Total Assets 77.88
Total Liabilities 77.88
Total Equity 19.43
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.81
Return on Capital (%) 8.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.36
Total Assets 55.71
Total Liabilities 55.71
Total Equity 15.70
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.88
Return on Capital (%) 7.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.91
Total Assets 188.71
Total Liabilities 188.71
Total Equity 49.86
Share Outstanding 17766200
Price to Book Ratio 0.00
Return on Assets (%) 6.79
Return on Capital (%) 11.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 112.48
Total Liabilities 112.48
Total Equity 25.18
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.86
Return on Capital (%) 6.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 78.27
Total Liabilities 78.27
Total Equity 19.71
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.76
Return on Capital (%) 8.46
Particulars MAR 2025 (Values in Cr)
Net Income 17.35
Cash from Operations 2.79
Cash from Investing -8.28
Cash from Financing 8.52
Net change in Cash 0.76
Free Cash Flow 11.66
Particulars MAR 2024 (Values in Cr)
Net Income 7.11
Cash from Operations -21.56
Cash from Investing -2.00
Cash from Financing 24.34
Net change in Cash -0.31
Free Cash Flow -19.19
Particulars MAR 2023 (Values in Cr)
Net Income 5.09
Cash from Operations 2.17
Cash from Investing -2.85
Cash from Financing 2.35
Net change in Cash 0.62
Free Cash Flow 5.07
Particulars MAR 2022 (Values in Cr)
Net Income 3.72
Cash from Operations 3.36
Cash from Investing -3.25
Cash from Financing 1.37
Net change in Cash 0.28
Free Cash Flow 6.63
Particulars MAR 2025 (Values in Cr)
Net Income 17.26
Cash from Operations -1.48
Cash from Investing -4.43
Cash from Financing 8.46
Net change in Cash 0.68
Free Cash Flow 3.55
Particulars MAR 2024 (Values in Cr)
Net Income 7.52
Cash from Operations -22.27
Cash from Investing -1.37
Cash from Financing 24.52
Net change in Cash -0.31
Free Cash Flow -20.76
Particulars MAR 2023 (Values in Cr)
Net Income 5.20
Cash from Operations 2.02
Cash from Investing -2.77
Cash from Financing 2.59
Net change in Cash 0.62
Free Cash Flow 4.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
EXCEL INDUSTRIES LTD 947.90 16.20 0.65 1191.58 798.50 / 1438.00
PUNJAB CHEM & CROP PROT L 1182.40 26.48 3.62 1449.62 669.55 / 1664.95
DHANUKA AGRITECH LTD 1179.15 18.22 3.78 5315.41 1091.60 / 1960.00
UPL LIMITED 804.25 28.22 2.12 67823.91 498.10 / 812.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
BAYER CROPSCIENCE LTD 4508.60 33.28 6.48 20262.59 4220.05 / 6539.95
EXCEL INDUSTRIES LTD 947.90 17.01 0.96 1191.58 798.50 / 1438.00
PUNJAB CHEM & CROP PROT L 1182.40 26.70 3.46 1449.62 669.55 / 1664.95
RALLIS INDIA LTD 274.05 31.21 2.59 5329.42 196.00 / 385.60

Mahamaya Lifesciences Ltd shareholding pattern

Holding

32.59%
56.34%
6.39%
4.66%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Mahamaya Lifesciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
196.95 4.92 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 188.40
  • 26 Days 159.10
  • 10 Days 182.90
  • 50 Days 149.60
  • 12 Days 180.30
  • 100 Days 149.60
  • 20 Days 169.50
  • 200 Days 149.60
185.23 PIVOT

First Support

182.77

First Resistance

190.17

Second Support

177.83

Second Resistance

192.63

Third Support

175.37

Third Resistance

197.57

RSI

72.86

ADX

67.80

MACD

21.18

Williams % R

-12.45

Commodity Channel Index (CCI)

80.98

Date

2026-01-02

Week

42400.00

Same Day

80400.00

Month

167322.00

1 Year

-0.65

3 Year

-0.79

Over 1 Month

66.06%

down

Over 1 Year

0.00%

down

Over 3 Months

69.78%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Mahamaya Lifesciences Ltd Corporate Actions

Mahamaya Lifesciences Ltd Share Price

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.

The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). The Company began the journey by focusing on import and registration of vital pesticide molecules. It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration, it marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.

In 2002, Company expanded from the sale of technical to companies, to establish its own manufacturing plant for formulations in December 2021, located in Dahej, Gujarat. From this manufacturing facility, it produce and sell bulk formulations, branded products (own brand products), and export them to customers. Domestically, it market the own branded products across states such as Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana through a well-established dealer network. Internationally, it export the products to countries including the Dominican Republic, Turkey, Egypt, and the UAE.

The Company introduced Norwegian seaweed extract based Bio-stimulants formulations. The expansion of bio-products in agriculture is a critical strategy to meet the growing demand for sustainable and eco-friendly agricultural solutions. Company incorporated a subsidiary in UAE in the name of 'Mahamaya Lifesciences FZE' to further promote the import and export operations in 2017.

The Company began construction of factory in Dahej, Gujarat in FY 2018 and completed it after getting the license to manufacture insecticides from the Govt of Gujarat in FY 2022.

The Company came up with the initial public offer of 61,78,800 Equity Shares of Rs 10/- each by raising Rs 70.44 Crore consisting a fresh issue of
56,38,800 Equity Shares aggregating to Rs 64.28 crores and the offer for sale of 5,40,000 Equity Shares aggregating to Rs 6.15 crores in November, 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 2002
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Mahamaya Lifesciences Ltd?

Answer Field

Mahamaya Lifesciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 196.95 as on Jan 02 2026 03:28 PM.

What is the Market Cap of Mahamaya Lifesciences Ltd Share?

Answer Field

The market cap of Mahamaya Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 461.00 as on Jan 02 2026 03:28 PM.

What is the 52 Week High and Low of Mahamaya Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Mahamaya Lifesciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 205.05 and ₹ 111.00.

What is 1 year return for Mahamaya Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Mahamaya Lifesciences Ltd Share?

Answer Field

As on Jan 02 2026 03:28 PM the price-to-earnings (PE) ratio for Mahamaya Lifesciences Ltd share is 35.94.

What is the PB ratio of Mahamaya Lifesciences Ltd Share?

Answer Field

As on Jan 02 2026 03:28 PM, the price-to-book (PB) ratio for Mahamaya Lifesciences Ltd share is 48.77.

How to Buy Mahamaya Lifesciences Ltd Share?

Answer Field

You can trade in Mahamaya Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mahamaya Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Mahamaya Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mahamaya Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59